http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021059937-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85201e840fef36e6cd45fb9a4b4f0343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_542b140b579c0b7996d62cc82416a98f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9dc8ebf1bf30f0a6ac6ab7b9972954ba
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01F21-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
filingDate 2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8179af220970f103321b7eb1b5f339ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b88c408830b39e220cbaee763293252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d613b39aff196baa3b5963ebec339c2
publicationDate 2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021059937-A1
titleOfInvention Liposome Formulation of Fluticasone Furoate and Method of Preparation
abstract The present invention is directed to a liposomal formulation having a lipid ingredient encapsulating fluticasone furoate, and a method for preparing the liposomal formulation. The liposome formulation comprises a lipid and a sterol. The method of preparing the liposomes comprises the steps of (1) mixing fluticasone furoate with lipid ingredients comprising a lipid and a sterol, (2) injecting the mixture into normal saline solution, and (3) ultrafiltering and concentrating the resulting solution. This preparation method can produce a liposome formulation having desirable properties and compositions, for example, the ratio of the lipid ingredient, the drug to lipid ratio, and the pH value, which is suitable for nebulization inhalation.
priorityDate 2019-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059579
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226499104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414110471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6999030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66587190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226604709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23658408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57847664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11540438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226502453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71307508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417324

Total number of triples: 76.